These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1308 related items for PubMed ID: 9649139

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Tumor progression driven by pathways activating matrix metalloproteinases and their inhibitors.
    Bodnar M, Szylberg Ł, Kazmierczak W, Marszalek A.
    J Oral Pathol Med; 2015 Jul; 44(6):437-43. PubMed ID: 25244188
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Enhanced production and activation of progelatinase A mediated by membrane-type 1 matrix metalloproteinase in human oral squamous cell carcinomas: implications for lymph node metastasis.
    Shimada T, Nakamura H, Yamashita K, Kawata R, Murakami Y, Fujimoto N, Sato H, Seiki M, Okada Y.
    Clin Exp Metastasis; 2000 Jul; 18(2):179-88. PubMed ID: 11235994
    [Abstract] [Full Text] [Related]

  • 5. Presence of active gelatinases in endometrial carcinoma and correlation of matrix metalloproteinase expression with increasing tumor grade and invasion.
    Di Nezza LA, Misajon A, Zhang J, Jobling T, Quinn MA, Ostör AG, Nie G, Lopata A, Salamonsen LA.
    Cancer; 2002 Mar 01; 94(5):1466-75. PubMed ID: 11920503
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Reduced expression of tissue inhibitor of metalloproteinase in nodal metastasis of stomach cancer.
    Ko BK, Cho HR, Choi DW, Nam CW, Park CJ, Kim GY, Kim SS, Woo YJ, Huh J, Kim MY.
    J Korean Med Sci; 1998 Jun 01; 13(3):286-90. PubMed ID: 9681807
    [Abstract] [Full Text] [Related]

  • 9. Distribution and synthesis of type VII collagen in oral squamous cell carcinoma.
    Kainulainen T, Grenman R, Oikarinen A, Greenspan DS, Salo T.
    J Oral Pathol Med; 1997 Oct 01; 26(9):414-8. PubMed ID: 9385579
    [Abstract] [Full Text] [Related]

  • 10. MMPs, TIMP-2, and TGF-beta1 in the cancerization of oral lichen planus.
    Chen Y, Zhang W, Geng N, Tian K, Jack Windsor L.
    Head Neck; 2008 Sep 01; 30(9):1237-45. PubMed ID: 18642282
    [Abstract] [Full Text] [Related]

  • 11. [Expression of matrix metalloproteinase-2, 9 and their inhibitor-TIMP 1,2 in human squamous cell carcinoma of uterine cervix].
    Zhou CY, Yao JF, Chen XD.
    Ai Zheng; 2002 Jul 01; 21(7):735-9. PubMed ID: 12479097
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Expressions of matrix metalloproteinases in early-stage oral squamous cell carcinoma as predictive indicators for tumor metastases and prognosis.
    Katayama A, Bandoh N, Kishibe K, Takahara M, Ogino T, Nonaka S, Harabuchi Y.
    Clin Cancer Res; 2004 Jan 15; 10(2):634-40. PubMed ID: 14760086
    [Abstract] [Full Text] [Related]

  • 14. Expression of matrix metalloproteinases MMP-2, MMP-9 and their tissue inhibitors TIMP-1, -2, and -3 in benign and malignant tumours of the salivary gland.
    Nagel H, Laskawi R, Wahlers A, Hemmerlein B.
    Histopathology; 2004 Mar 15; 44(3):222-31. PubMed ID: 14987225
    [Abstract] [Full Text] [Related]

  • 15. Expression of matrix metalloproteinases (MMP-2, MMP-9, MT1-MMP) and their inhibitors (TIMP-1, TIMP-2) in common epithelial tumors of the ovary.
    Sakata K, Shigemasa K, Nagai N, Ohama K.
    Int J Oncol; 2000 Oct 15; 17(4):673-81. PubMed ID: 10995877
    [Abstract] [Full Text] [Related]

  • 16. [The effects of MMPs and TIMPs on the metastasis of oral squamous cell carcinoma to neck lymph nodes].
    Liu G, Li J, Li Z, Chen X.
    Hua Xi Kou Qiang Yi Xue Za Zhi; 2001 Aug 15; 19(4):216-8, 224. PubMed ID: 12539723
    [Abstract] [Full Text] [Related]

  • 17. Regulated expression of matrix metalloproteinases and TIMP in nephrogenesis.
    Tanney DC, Feng L, Pollock AS, Lovett DH.
    Dev Dyn; 1998 Sep 15; 213(1):121-9. PubMed ID: 9733107
    [Abstract] [Full Text] [Related]

  • 18. Activation of MMP-2 and MMP-9 in patients with oral squamous cell carcinoma.
    Patel BP, Shah PM, Rawal UM, Desai AA, Shah SV, Rawal RM, Patel PS.
    J Surg Oncol; 2005 May 01; 90(2):81-8. PubMed ID: 15844188
    [Abstract] [Full Text] [Related]

  • 19. Overexpression of matrix metalloproteinase-1 and -9 mRNA is associated with progression of oral dysplasia to cancer.
    Jordan RC, Macabeo-Ong M, Shiboski CH, Dekker N, Ginzinger DG, Wong DT, Schmidt BL.
    Clin Cancer Res; 2004 Oct 01; 10(19):6460-5. PubMed ID: 15475433
    [Abstract] [Full Text] [Related]

  • 20. 92K-GL (MMP-9) and 72K-GL (MMP-2) are produced in vivo by human oral squamous cell carcinomas and can enhance FIB-CL (MMP-1) activity in vitro.
    Pickett KL, Harber GJ, DeCarlo AA, Louis P, Shaneyfelt S, Windsor LJ, Bodden MK.
    J Dent Res; 1999 Jul 01; 78(7):1354-61. PubMed ID: 10403463
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 66.